Capital Gap Development stage oncology firms struggle to secure funding due to a mismatch between early stage investors and larger strategic investors. Oncology Partners LLC can tailor investment narratives and connect companies with a broader network to bridge this financing gap.

De-risking Programs There is strong demand from pharmaceutical partners for robust data to de-risk assets before licensing or co-development deals. Offer services to design and execute data generation plans that enable faster, higher-quality conversations with potential licensees.

Management & Talent Gaps in leadership and key opinion leader recruitment are recurring constraints for development-stage companies. Provide targeted advisory and recruiting support to strengthen management teams and scientific credibility, increasing attractiveness to investors and partners.

Strategic Partnerships A credible pathway from early funding to larger institutional investment exists through bespoke storytelling and network access. Position as a conduit to connect startups with strategic partners and large funders, accelerating deal flow.

Market Readiness With revenue in the low to mid single digits and a focused oncology thesis, target opportunities where demonstrated progress can unlock larger introductions to well-capitalized buyers or sponsors seeking out-licensing or co-development collaborations.